why choose us

First received: April 19, 2023

Clinical Trial: Safety and Pharmacodynamics of GNSC-001 Intra-articular Injection for Knee Osteoarthritis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Osteoarthritis, Knee

Study Type: INTERVENTIONAL


Official Title: A Phase 1b, Randomized, Double-Blinded, Placebo-Controlled Dose Ranging Study to Evaluate Safety, Tolerability and Pharmacodynamics of a Single Intra-articular Injection of GNSC-001 Gene Therapy in Su

Brief Summary: The goal of this clinical study is to determine if a single injection of 1 or more dose levels of adeno-associated virus (AAV) gene therapy (GNSC-001) is safe and tolerated compared to placebo in participants with painful osteoarthritis (OA) of the knee.

Read more